Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 27, Issue 10, Pages 999-1015
Publisher
Informa UK Limited
Online
2023-10-03
DOI
10.1080/14728222.2023.2266572
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis of Veliparib Prodrugs and Determination of Drug-Release-Dependent PARP-1 Inhibition
- (2023) Matteo Borgini et al. ACS Medicinal Chemistry Letters
- Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells
- (2023) Biswajit Das et al. Journal of Cell Communication and Signaling
- Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells
- (2023) Biswajit Das et al. PHYTOMEDICINE
- Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping
- (2022) Subhajit Chatterjee et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls
- (2022) Sola Adeleke et al. Personalized Medicine
- Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway
- (2022) Saptarshi Sinha et al. EXPERIMENTAL CELL RESEARCH
- Targeting cancer stem cells in the tumor microenvironment: An emerging role of PARP inhibitors
- (2022) Subarno Paul et al. PHARMACOLOGICAL RESEARCH
- Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A
- (2022) Deepika Nayak et al. Journal of Cell Communication and Signaling
- Surgery for T4 Colorectal Cancer in Older Patients: Determinants of Outcomes
- (2022) Michael Osseis et al. Journal of Personalized Medicine
- Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway
- (2022) Rajalaxmi Pradhan et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition
- (2021) Chinmayee Sethy et al. BIOMEDICINE & PHARMACOTHERAPY
- Olaparib enhances curcumin-mediated apoptosis in oral cancer cells by inducing PARP trapping through modulation of BER and chromatin assembly
- (2021) Sefinew Molla et al. DNA REPAIR
- PARP1-modulated chromatin remodeling is a new target for cancer treatment
- (2021) Saptarshi Sinha et al. MEDICAL ONCOLOGY
- Exploration of Benzo[b]carbazole-6,11-diones as anticancer agents: Synthesis and studies of hTopoIIα inhibition and apoptotic effects
- (2021) Shailendra Sisodiya et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells
- (2021) Somya Ranjan Dash et al. Nanomedicine-Nanotechnology Biology and Medicine
- Tumor Microenvironment
- (2020) Borros Arneth Medicina-Lithuania
- 5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
- (2020) Sabrina Blondy et al. CANCER SCIENCE
- Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse
- (2019) Chinmayee Sethy et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Quinacrine and curcumin synergistically increased the breast cancer stem cells death by inhibiting ABCG2 and modulating DNA damage repair pathway
- (2019) Deepika Nayak et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
- (2018) Lan Thi Hanh Phi et al. Stem Cells International
- ABT-888 and quinacrine induced apoptosis in metastatic breast cancer stem cells by inhibiting base excision repair via adenomatous polyposis coli
- (2016) Sumit Siddharth et al. DNA REPAIR
- Pharmacologic resistance in colorectal cancer: a review
- (2015) William A. Hammond et al. Therapeutic Advances in Medical Oncology
- 5-Fluorouracil mediated anti-cancer activity in colon cancer cells is through the induction of Adenomatous Polyposis Coli: Implication of the long-patch base excision repair pathway
- (2014) Dipon Das et al. DNA REPAIR
- Targeting DNA repair pathways for cancer treatment: what’s new?
- (2014) Mark R Kelley et al. Future Oncology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- PARP-1 enhances the mismatch-dependence of 5′-directed excision in human mismatch repair in vitro
- (2011) Yiyong Liu et al. DNA REPAIR
- DNA mismatch repair (MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets
- (2009) Long Shan Li et al. BRITISH JOURNAL OF PHARMACOLOGY
- Participation of DNA repair in the response to 5-fluorouracil
- (2008) M. D. Wyatt et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The mismatch repair-mediated cell cycle checkpoint response to fluorodeoxyuridine
- (2008) Angen Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started